133 related articles for article (PubMed ID: 3782248)
1. Management of rachitic deformities in children with chronic renal failure.
Blockey NJ; Murphy AV; Mocan H
J Bone Joint Surg Br; 1986 Nov; 68(5):791-4. PubMed ID: 3782248
[TBL] [Abstract][Full Text] [Related]
2. Bone maturation in children with chronic renal failure. Effect of 1 alpha-hydroxy vitamin D3 and renal transplantation.
Johannsen A; Nielsen HE; Hansen HE
Acta Radiol Diagn (Stockh); 1979; 20(1):193-9. PubMed ID: 377915
[TBL] [Abstract][Full Text] [Related]
3. The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
Meyrier A; Marsac J; Richet G
Kidney Int; 1973 Aug; 4(2):146-53. PubMed ID: 4744972
[No Abstract] [Full Text] [Related]
4. The radiographic spectrum of renal osteodystrophy.
Molpus WM; Pritchard RS; Walker CW; Fitzrandolph RL
Am Fam Physician; 1991 Jan; 43(1):151-8. PubMed ID: 1986484
[TBL] [Abstract][Full Text] [Related]
5. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of uremic osteodystrophy].
Fletti C; Docci D; Coli' L; Di Felice A
G Clin Med; 1981 Apr; 62(4):270-9. PubMed ID: 7021295
[No Abstract] [Full Text] [Related]
7. Calcitriol and calcium carbonate therapy in early chronic renal failure.
Fournier A
Nephrol Dial Transplant; 1995; 10(4):577. PubMed ID: 7624009
[No Abstract] [Full Text] [Related]
8. Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy.
Watson AR; Kooh SW; Tam CS; Reilly BJ; Balfe JW; Vieth R
Child Nephrol Urol; 1988-1989; 9(4):220-7. PubMed ID: 3255485
[TBL] [Abstract][Full Text] [Related]
9. Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3.
Postlethwaite RJ; Houston IB
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():117s-124s. PubMed ID: 304772
[TBL] [Abstract][Full Text] [Related]
10. [1 alpha-hydroxycholecalciferol treatment of a 2-year-old child with severe renal osteodystrophy].
Hansen HE; Christensen MS; Nielsen HE; Johannsen A
Ugeskr Laeger; 1978 Apr; 140(16):919-21. PubMed ID: 653843
[No Abstract] [Full Text] [Related]
11. Fluoride and dialysis osteodystrophy: results of a double-blind study.
Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA
Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422
[No Abstract] [Full Text] [Related]
12. [Opinionnaire survey on the treatment of renal osteodystrophy in Japan].
Morii H
Nihon Jinzo Gakkai Shi; 1983 Apr; 25(4):439-47. PubMed ID: 6620696
[No Abstract] [Full Text] [Related]
13. Whole-body in-vivo neutron activation analysis in assessing treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.
Naik RB; Gosling P; Price CP; Robinson BH; Dabek JT; Heath DA; James HM; Kanis JA; Smith R
Br Med J; 1976 Jul; 2(6027):79-83. PubMed ID: 1276820
[TBL] [Abstract][Full Text] [Related]
14. Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate binders.
Turner C; Compston J; Mak RH; Vedi S; Mellish RW; Haycock GB; Chantler C
Kidney Int; 1988 May; 33(5):989-95. PubMed ID: 3392888
[TBL] [Abstract][Full Text] [Related]
15. [Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].
Kakuhara T; Mizoguchi M; Itoh M; Nagasawa M; Mori T; Ohtsuka K; Kubota M; Minatoguchi T; Ohara K; Yoshida M; Koide H; Ohno J
Nihon Jinzo Gakkai Shi; 1982 Jun; 24(6):693-704. PubMed ID: 7176180
[No Abstract] [Full Text] [Related]
16. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy].
Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M
Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442
[TBL] [Abstract][Full Text] [Related]
17. Renal osteodystrophy in children: progress in its management.
Chan JC
Clin Pediatr (Phila); 1976 Nov; 15(11):996-1002. PubMed ID: 975714
[No Abstract] [Full Text] [Related]
18. Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Monitoring the calcium-phosphate product is important.
McGregor MS; Rowe PA; Junor BJ
BMJ; 1995 Jul; 311(6997):124; author reply 124-5. PubMed ID: 7613376
[No Abstract] [Full Text] [Related]
19. [Progression of hyperparathyroidism during hemodialysis. Response to conservative treatment].
García de Vinuesa S; Luño J; González C; Resano M; Allés A; Olivas E; Barril G; Valderrábano F
Rev Clin Esp; 1982 Feb; 164(3):163-7. PubMed ID: 6896386
[No Abstract] [Full Text] [Related]
20. The wide spectrum of renal osteodystrophy in children.
Wolfson BJ; Capitanio MA
Crit Rev Diagn Imaging; 1987; 27(4):297-319. PubMed ID: 3322679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
